Skip to main content
. 2019 Apr 5;14(4):e0215021. doi: 10.1371/journal.pone.0215021

Fig 2. Clinical Course of patients with Hodgkin Lymphoma and Aplastic Anemia.

Fig 2

A schematic diagram demonstrating the clinical course of 15 patients with diagnoses of HL and AA. Patient reported by Brusamolino et al. is not shown because of incomplete clinical information. Blue triangle, HL diagnosis; red circle, AA diagnosis; black triangle, death; green cross, last follow-up. Treatments for HL and AA are denoted by black vertical lines, with treatment and response listed above the respective line. HL, Hodgkin Lymphoma; AA, Idiopathic Acquired Aplastic Anemia; ABVD, Doxorubicin, Bleomycin, Vinblastine, Dacarbazine; ASHAP, Doxorubicin, Solumedrol, Cytarabine, Cisplatin; MOPP, Mechlorethamine, Vincristine, Procarbazine, Prednisone; MTNI, Modified Total Nodal Irradiation; C-MOPP, Cyclophosphamide, Vincristine, Procarbazine, Prednisone; CHOP, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; Allo BMT, Allogenic Bone Marrow Transplant; hATG, Horse Antithymocyte Globulin; ATG, Antithymocyte Globulin; ALG, Antilymphocyte Globulin, CsA, Cyclosporine A; Tac, Tacrolimus; G-CSF, Granulocyte Colony Stimulating Factor; CR, Complete Response; PR, Partial Response; NR, No Response.